BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 26, 2007
 |  BioCentury  |  Finance

EPS watch

EPS watch

EPS watch
Actelion (SWX:ATLN) fell 11% last week despite posting 4Q06 EPS growth of 170% vs. the year-prior quarter. Investors apparently have some concerns about what’s ahead for the company (see "Actelion’s Quiet Period," A20). Conversely, United Therapeutics (UTHR) was the big winner - adding 14% - after posting EPS and revenues that beat the Street consensus. $M
Company 4Q06 EPS est 4Q06 EPS actual Outcome Growth from...

Read the full 376 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >